CA2863389A1 - Antacid tablet - Google Patents
Antacid tablet Download PDFInfo
- Publication number
- CA2863389A1 CA2863389A1 CA2863389A CA2863389A CA2863389A1 CA 2863389 A1 CA2863389 A1 CA 2863389A1 CA 2863389 A CA2863389 A CA 2863389A CA 2863389 A CA2863389 A CA 2863389A CA 2863389 A1 CA2863389 A1 CA 2863389A1
- Authority
- CA
- Canada
- Prior art keywords
- tablet
- present
- antacid tablet
- tablets
- hardness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title abstract 4
- 229940069428 antacid Drugs 0.000 title abstract 2
- 239000003159 antacid agent Substances 0.000 title abstract 2
- 230000001458 anti-acid effect Effects 0.000 title abstract 2
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
- 239000011436 cob Substances 0.000 abstract 1
- 201000006549 dyspepsia Diseases 0.000 abstract 1
- 208000024798 heartburn Diseases 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261594055P | 2012-02-02 | 2012-02-02 | |
| US61/594,055 | 2012-02-02 | ||
| PCT/US2013/024078 WO2013116477A1 (en) | 2012-02-02 | 2013-01-31 | Antacid tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2863389A1 true CA2863389A1 (en) | 2013-08-08 |
Family
ID=48905820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2863389A Abandoned CA2863389A1 (en) | 2012-02-02 | 2013-01-31 | Antacid tablet |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20140037759A1 (enExample) |
| EP (1) | EP2809331A4 (enExample) |
| CN (1) | CN104136033A (enExample) |
| AR (1) | AR089857A1 (enExample) |
| BR (1) | BR112014019155A8 (enExample) |
| CA (1) | CA2863389A1 (enExample) |
| CO (1) | CO7020922A2 (enExample) |
| HK (1) | HK1201179A1 (enExample) |
| IN (1) | IN2014DN06198A (enExample) |
| MX (1) | MX2014009391A (enExample) |
| WO (1) | WO2013116477A1 (enExample) |
| ZA (1) | ZA201405354B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025222289A1 (en) * | 2024-04-23 | 2025-10-30 | Biovantek | Calcium carbonate formulations and method of treatment of gastroesophageal reflux disease (gerd) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ243567A (en) * | 1991-07-22 | 1995-04-27 | Bristol Myers Squibb Co | Pharmaceutical oral formulation of a dideoxy purine nucleoside comprising the nucleoside together with a water-insoluble antacid buffering composition |
| GB9825033D0 (en) * | 1998-11-13 | 1999-01-13 | Nycomed Pharma As | Process |
| US6358526B1 (en) * | 2000-08-16 | 2002-03-19 | Rexall Sundown | Method of making tablets and tablet compositions produced therefrom |
| WO2004064719A2 (en) * | 2003-01-24 | 2004-08-05 | State Of Israel, Ministry Of Agriculture | Synergistic compositions and methods for potentiating anti-oxidative activity |
| WO2004073632A2 (en) * | 2003-02-19 | 2004-09-02 | Biovail Laboratories Inc. | Rapid absorption selective 5-ht agonist formulations |
| UA95093C2 (uk) * | 2005-12-07 | 2011-07-11 | Нікомед Фарма Ас | Спосіб одержання кальцієвмісної сполуки |
| AR061093A1 (es) * | 2006-05-12 | 2008-08-06 | Drug Tech Corp | Composiciones de calcio |
-
2013
- 2013-01-30 AR ARP130100289A patent/AR089857A1/es unknown
- 2013-01-31 US US13/755,229 patent/US20140037759A1/en not_active Abandoned
- 2013-01-31 BR BR112014019155A patent/BR112014019155A8/pt not_active IP Right Cessation
- 2013-01-31 MX MX2014009391A patent/MX2014009391A/es unknown
- 2013-01-31 CA CA2863389A patent/CA2863389A1/en not_active Abandoned
- 2013-01-31 EP EP13743888.3A patent/EP2809331A4/en not_active Ceased
- 2013-01-31 IN IN6198DEN2014 patent/IN2014DN06198A/en unknown
- 2013-01-31 WO PCT/US2013/024078 patent/WO2013116477A1/en not_active Ceased
- 2013-01-31 CN CN201380010222.5A patent/CN104136033A/zh active Pending
- 2013-01-31 HK HK15101650.2A patent/HK1201179A1/xx unknown
-
2014
- 2014-07-21 ZA ZA2014/05354A patent/ZA201405354B/en unknown
- 2014-07-31 CO CO14167105A patent/CO7020922A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104136033A (zh) | 2014-11-05 |
| EP2809331A4 (en) | 2015-07-15 |
| WO2013116477A1 (en) | 2013-08-08 |
| CO7020922A2 (es) | 2014-08-11 |
| ZA201405354B (en) | 2015-11-25 |
| BR112014019155A8 (pt) | 2017-07-11 |
| HK1201179A1 (en) | 2015-08-28 |
| AR089857A1 (es) | 2014-09-24 |
| MX2014009391A (es) | 2014-08-27 |
| BR112014019155A2 (enExample) | 2017-06-20 |
| EP2809331A1 (en) | 2014-12-10 |
| IN2014DN06198A (enExample) | 2015-10-23 |
| US20140037759A1 (en) | 2014-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202202711B (en) | Sustained-release dosage forms of ruxolitinib | |
| MY159630A (en) | Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof | |
| TN2009000093A1 (en) | Pharmaceutical compositions comprising nilotinib or its salt | |
| UA92641C2 (ru) | Комбинированная препаративная форма, которая содержит амлодипин и лозартан | |
| MX343358B (es) | Tabletas de acetato de ulipristal. | |
| UA92077C2 (uk) | Таблетка, що диспергується у роті | |
| MY157673A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
| PH12012502082A1 (en) | Combination of active loaded granules with additional actives | |
| WO2011090694A8 (en) | Orally administrable film dosage forms containing ondansetron | |
| TN2015000135A1 (en) | Modified release formulations for oprozomib | |
| WO2007134158A3 (en) | Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy | |
| MX2010001705A (es) | Co-cristales de pirimetanilo y ditianona. | |
| MX2009008108A (es) | Composicion farmaceutica que contiene una combinacion de tramadol y ketoprofeno. | |
| IN2014MN01382A (enExample) | ||
| WO2011091410A8 (en) | Trpv4 antagonists | |
| CA2863389A1 (en) | Antacid tablet | |
| WO2009106960A3 (en) | Stable compositions of lamivudine, tenofovir and efavirenz | |
| WO2009060064A3 (en) | Pharmaceutical formulations for the oral administration of ppi | |
| EA201001108A1 (ru) | Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения | |
| MX2012002209A (es) | Formulaciones de liberacion controlada de compuestos de anabaseina y usos de los mismos. | |
| WO2011161223A3 (en) | Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts | |
| BR112013000870A2 (pt) | forma de dosagem farmacêutica oral em comprimidos | |
| WO2010084111A3 (en) | Pharmaceutical composition of ibandronate sodium salt or a hydrate thereof | |
| WO2006093786A3 (en) | Scopolamine sublingual spray | |
| MX2011009844A (es) | Composicion farmaceutica que comprende alisquireno. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20190131 |